İnflamatuvar Bağırsak Hastalığı Nedeniyle Biyolojik Ajan Tedavisi Alan Kadınların Emzirdikleri Süt Çocuklarında İlaç Maruziyet Düzeyleri ve Emzirmenin Gelişim, Enfeksiyonlar Üzerine Etkisi

References (10)

1. Murdaca G, Spanò F, Contatore M, et al. Infection risk associated with anti-TNF-α agents: a review. Expert Opin Drug Saf 2015;14:571-82. Fréling E, Baumann C, Cuny JF, et al. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience. Am J Gastroenterol 2015;110:1186-96.
2. Lee YH, Bae SC, Song GG. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy. Clin Exp Rheumatol 2013;31:118-21.
3. Pereira R, Lago P, Faria R, et al. Safety of Anti-TNF therapies in immune-mediated inflammatory diseases: focus on infections and malignancy. Drug Dev Res 2015;76:419-27. van Assen S, Agmon-Levin N, Elkayam O, et al EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414-22.
4. Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2016;68:1-25.
5. Aikawa NE, França IL, Ribeiro AC, et al. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy. Vaccine 2015;33:604-9.
6. Ingelman-Sundberg HM, Laestadius Å, Chrapkowska C, et al. Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-α therapy in children with rheumatic diseases: A cross-sectional study. Vaccine 2016;34:1304-11.
7. Kane S, Ford J, Cohen R, Wagner C. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn’s disease before and after delivery. J Clin Gastroenterol 2009;43:613-6.
8. Hou JK, Mahadevan U. A 24-year-old pregnant woman with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009;7:944-7.
9. Weber-Schoendorfer C, Oppermann M, Wacker E, et al. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br J Clin Pharmacol 2015;80:727-39. Solomon BD. VACTERL/VATER Association. Orphanet J Rare Dis 2011;6:56. Amin M, No DJ, Egeberg A, et al. Choosing first-line biologic treatment for moderate-to-severe psoriasis: What does the evidence say? Am J Clin Dermatol 2018;19:1-13.
10. Gotestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider f